Indocyanine Green (ICG) Guided Tumor Resection — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Indocyanine Green (ICG) Guided Tumor Resection — Stella

Home/Neoplastic Disease/

View on ClinicalTrials.gov

Recruiting

Back to Neoplastic Disease trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

St. Jude Children's Research Hospital, Memphis, Tennessee

Key details

Phase

Early testing

Sponsor

St. Jude Children's Research Hospital

Enrollment target

~230 participants

Started

February 2020

Primary completion

August 2026

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.